Systematic literature review and meta-analysis of US-approved LAMA/LABA therapies versus tiotropium in moderate-to-severe COPD

Dual bronchodilator maintenance therapy may benefit patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) versus long-acting muscarinic antagonist (LAMA) monotherapy. The efficacy and safety of US-approved LAMA/long-acting beta-agonist (LABA) combinations versus tiotropium (T...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, MeiLan K., Ray, Riju, Foo, Jason, Morel, Chaienna, Hahn, Beth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110857/
https://www.ncbi.nlm.nih.gov/pubmed/30150639
http://dx.doi.org/10.1038/s41533-018-0099-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110857/
https://www.ncbi.nlm.nih.gov/pubmed/30150639
http://dx.doi.org/10.1038/s41533-018-0099-1

Ejemplares similares